Behind KANJINTI®

ANSWERING THE GROWING
NEED FOR BIOSIMILARS

Amgen is a leader in biologics with a growing portfolio of biosimilars.

HERITAGE

The healthcare community has been able to trust us for decades

AMGEN Biologics – over 40 years of experience
AMGEN Biologics – over 40 years of experience AMGEN Biologics – over 40 years of experience

AT AMGEN, WE’RE COMMITTED TO DELIVERING QUALITY PRODUCTS TO EVERY PATIENT, EVERY TIME

EXPERTISE

Real-world experience and expertise paved the way for our leadership in biosimilars

Over 300 Quality Checks During Manufacturing Over 300 Quality Checks During Manufacturing

*Available biosimilars across all global markets.

†As of [June 30, 2025]. Number of non-oncology patients calculated from duration of therapy and adherence data from IQVIA Analytics Link and IQVIA Patient Link, respectively. Number of oncology patients determined using claims data (US) and physician surveys (ex-US). Patient count estimates may not accurately reflect the actual number of patients treated with Amgen biosimilars if adherence or length of treatment in real world differs from the assumptions used.

Commitment

WE ARE A LONG-STANDING BIOTECHNOLOGY LEADER COMMITTED TO
DEVELOPING THE BIOSIMILAR MARKETPLACE

Invested in the development of biosimilars and novel therapeutics

In the last decade, AMGEN® has achieved zero supply shortages In the last decade, AMGEN® has achieved zero supply shortages

Support

WE ARE COMMITTED TO PROVIDING SOLUTION-ORIENTED RESOURCES THAT CAN HELP PROVIDE POSITIVE BIOSIMILAR EXPERIENCES

Amgen Support Amgen Support
AMGEN® Biosimilars

Learn more about Amgen’s commitment to biosimilars.

Amgen Biosimilars

Learn how Amgen uses the same support programs
for KANJINTI® as we do for our innovative treatments.

btn-medi_rainbow-svgsupport
amgen-oncology_logo

To stay up-to-date on Amgen’s advances in oncology, visit AmgenOncology.com.

Amgen Biosimilars
×
Amgen stands with our local Los Angeles community. Click here to learn what we are doing to support and contact us if the fires have impacted your access to Amgen medication.